FAQs

There is no universal threshold, but the relevant question is whether the construction introduces interface interactions, tolerance accumulation, or process sequencing constraints that would not exist in a simpler construction. A two-layer construction with dissimilar materials and a tight finished tolerance can present the same design-for-manufacturability challenges as a five-layer construction with more forgiving specifications. Layer count is a proxy for complexity, not a definition of it.

Not typically. Adhesive failures originate during converting, which requires specialized process control and material expertise.

Some can perform limited converting, but most are not structured for complex multilayer, adhesive-based, or contamination-sensitive applications that require specialized process control.

Sometimes. Customer-owned steel rule, flatbed, and rotary dies may be usable if they are compatible with the new supplier’s equipment and in good condition. The receiving supplier should inspect the tooling and confirm whether it will be used as-is, modified, or replaced before first article.

Yes. ISO 13485 certification scope, cleanroom classification, and process validation records are application-specific. A supplier qualified for medical device wearable components may not be qualified for microfluidic substrates or implantable device components. Qualification scope should match the application, not just the supplier.

Yes. Some suppliers maintain cleanrooms but only apply them to specific operations or products. Confirm that cleanroom conditions are integrated directly into the converting processes for your project—laminating, die cutting, slitting—and ask for documentation showing how those processes are controlled and monitored under cleanroom conditions.

Yes. Advantage Converting performs precision converting in ISO 7 and ISO 8 cleanroom environments for applications requiring contamination control.

Advantage Converting supports material evaluation as part of engineering prototyping and process development. A technical review can evaluate material and substrate requirements, layer construction, tolerances, converting requirements and manufacturability.

Yes. Advantage Converting supports engineering prototyping and process development and helps transition precision converted components toward repeatable production.

It depends on the device and the change. Medical device manufacturers evaluate supplier changes under their own quality system — ISO 13485:2016 and, in the United States, FDA’s Quality Management System Regulation (21 CFR Part 820). Some supplier changes can be managed internally through change control and supplier qualification; others may affect regulatory filings. That determination belongs to the device manufacturer’s regulatory team.

The distinction requires lot traceability and process documentation. If a supplier can correlate yield data with specific material lots and specific process parameters, they can usually isolate the cause. If they cannot, both variables are suspect. A supplier without lot traceability cannot reliably distinguish material-driven from process-driven yield loss.

Process changes during scale-up — new tooling, higher volumes, different material lots — must go through change control under ISO 13485:2016. Components developed at an R&D or developmental level are not yet operating under a validated production process. Scaling up requires demonstrating that the production process consistently meets specification under real production conditions, which means validation steps are required before full production release — not just operational adjustments. This makes the transition to production-level manufacturing a defined quality event, not just an operational one.